TOMORROW FOCUS AG 28.10.2013 14:02 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- On October 25, 2013, ETHENEA Independent Investors S.A., 5365 Munsbach, Luxembourg has informed us according to Article 21, Section 1 of the WpHG that via shares its Voting Rights on TOMORROW FOCUS AG, München, Deutschland, have fallen below the 3% threshold of the Voting Rights on October 24, 2013 and on that day amounted to 2.85% (this corresponds to 1665000 Voting Rights). 28.10.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: TOMORROW FOCUS AG Neumarkter Str. 61 81673 München Germany Internet: www.tomorrow-focus.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-PVR: TOMORROW FOCUS AG: Release according to Article
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Investigation of Stock Transactions: TASK, VBTX, TURN Insights
Financial Investigations for Shareholders of TASK, VBTX, and TURN Halper Sadeh LLC is actively investigating several companies regarding potential violations of federal securities laws affecting shareholders. The investigations focus on significant transactions involving TaskUs, Veritex Holdings, and 180 Degree Capital Corp. TaskUs, Inc. and Its Acquisition by Blackstone...
Continue Reading
Comprehensive Analysis of NVIDIA in the Semiconductor Market
Understanding NVIDIA's Position in the Semiconductor Sector In today's fast-paced business environment, it is crucial for investors and industry followers to conduct in-depth analyses of key companies. This article offers a detailed comparison of NVIDIA (NASDAQ: NVDA) with its main competitors in the Semiconductors & Semiconductor Equipment sector. By looking at important...
Continue Reading
Invivyd Set to Showcase PEMGARDA™ Findings at Upcoming Event
Invivyd Prepares for IDWeek 2024 Presentations Invivyd, Inc. (NASDAQ: IVVD) is an innovative biopharmaceutical company focusing on creating solutions for serious viral infections. As they gear up for their participation in IDWeek 2024, they will be unveiling exciting new data concerning their investigational monoclonal antibody, PEMGARDA™ (pemivibart). The conference is...
Continue Reading
The Rising Stars: Growth Potential of Key Investments
Carnival made waves post-pandemic as it clawed its way back from meme stock purgatory. Traders watched the cruise line stumble but now see flickers of recovery amidst hefty debt burdens that peaked around $35 billion. Sure, they pulled in a whopping $1.7 billion net income in the last quarter, but those profit forecasts? All over the place—talk about a mixed bag. And...
Continue Reading
PharmAla Partners with Logistics Expert for Clinical Trials
PharmAla Forms Strategic Alliance for Enhanced US Distribution PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a dedicated biotechnology company, is excited to share its latest strategic move aimed at improving service delivery in the United States. The company has engaged a trusted third-party logistics partner, specialized...
Continue Reading